Gwenn’s Law
This bill, known as Gwenn's Law, directs the National Institutes of Health to launch public awareness campaigns aimed at increasing women's participation in clinical trials, with a specific focus on research for rare diseases. It authorizes $10 million annually from 2027 to 2031 to fund these outreach efforts at hospitals, clinics, and other healthcare locations. The legislation also establishes a permanent interagency task force within HHS to coordinate rare disease research and requires the department to submit a public action plan within 180 days outlining how to improve treatment options for rare conditions that disproportionately affect women.
Bill status
in committee
1 of 4 stages cleared
Introduction
Feb 2026
Committee Review
Floor Vote
President
Introduced Feb 25, 2026
Last action Feb 25, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Feb 25, 2026
Committee
Referred to the House Committee on Energy and Commerce.
lower
Feb 25, 2026
Introduced
Introduced in House
lower
1 primary · 3 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Josh Gottheimer
DDemocratic
Co
Brian K. Fitzpatrick
RRepublican
Co
Brittany Pettersen
DDemocratic
Co
Michael Lawler
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 7694
Scope: US
Hi! I can help you understand HR 7694. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline